GTC Biotherapeutics (fka GTCB)

[croumagnon]

How low can it go?

My effective basis in the stock is $1.18, so I am not panicked yet at $1.14 as I consider a temporary paper loss under 15% as par for the course in small biotechs. However, I am truly surprised at the lack of buying interest in GTCB at this point in time. Dew refutes all our conspiracy theories relating to capping and/or cheap takeover attempts but the behavior of this stock is nevertheless quite puzzling given all the good news lately as well as the potential future...

Any intelligent explanations/conjectures would be greatly appreciated...